Schedule 13G ownership disclosure
Principia Biopharma Inc.
Security class unavailable · CUSIP: 74257L108
Event date: 2018-09-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.1200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-18-000778
- Form type
- SC 13G
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Sep 27, 2018
- Reporting period
- Sep 18, 2018
- Description
- Schedule 13G beneficial ownership